Visit | Screen | Enrollment | Baseline | Titrate* | Follow-up | ||
---|---|---|---|---|---|---|---|
Months | 0 | 2-4 weeks | 1 | 2-3 | 3 | 6 | 12 |
Informed Consent/Eligibility | X | X | Â | Â | Â | X | Â |
Medication Inventory | Â | X | X | X | X | X | X |
Weight/Height | Â | Â | X | Â | Â | X | X |
Blood pressure (2 every 5 min) | X | X | X | X | X | X | X |
Psychological Assessment | X | Â | X | Â | Â | X | X |
Cerebrovascular Assessment | Â | Â | X | Â | Â | X | X |
Biochemical Measures | Â | X | Â | X | X | X | X |
Renin/Aldosterone | Â | Â | X | Â | Â | X | X |
Adverse Events Screening | Â | Â | Â | X | X | X | X |